Filing Details
- Accession Number:
- 0000885590-11-000037
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-13 14:52:17
- Reporting Period:
- 2011-06-09
- Filing Date:
- 2011-06-13
- Accepted Time:
- 2011-06-13 14:52:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885590 | Valeant Pharmaceuticals International Inc. | VRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1508799 | Jr Walden Philip Loberg | C/O 7150 Mississauga Road Mississauga A6 L5N 8M5 | Evp, Interim Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, No Par Value | Acquisiton | 2011-06-09 | 7,500 | $52.82 | 137,565 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.64 to $53.00, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- This number includes 20,694 Performance based Restricted Share Units that were previously reported in Table I.
Billionaire Hedge Funds
